Clinical Trials Directory

Trials / Unknown

UnknownNCT03001284

Multiple Sclerosis Produces Cardiovascular Subclinical Dysfunction

Status
Unknown
Phase
Study type
Observational
Enrollment
103 (actual)
Sponsor
Carol Davila University of Medicine and Pharmacy · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Multiple sclerosis (MS), debilitating disease involving primarily the central nervous system, may cause cardiovascular dysfunction, due to autonomous nervous system dysfunction, physical invalidity, increased oxidative stress, and systemic inflammatory status, but the detailed mechanisms are not elucidated. The investigators aimed to assess left and right ventricular (LV and RV) function, left atrial (LA) function, arterial function, and atrial-ventricular-arterial coupling in patients with MS, compared to control subjects. LV systolic and diastolic function and RV function were assessed by 2D- and 3D- echocardiography, tissue Doppler, and speckle tracking echocardiography. LA function was assessed by LA volume index and LA strain. Arterial remodeling and stiffness were assessed by intima media-thickness, pulse wave velocity, and parameters of wave intensity and endothelial function

Conditions

Interventions

TypeNameDescription
OTHERNO intervention

Timeline

Start date
2012-10-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2016-12-23
Last updated
2016-12-23

Source: ClinicalTrials.gov record NCT03001284. Inclusion in this directory is not an endorsement.